HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
批准号:
2633775
负责人:
ALPHONSE E SIRICA
金额:
$24.92万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-02-16 至 2000-12-31
关键词:
3T3 cells adenocarcinoma bile ducts biliary tract neoplasm cell differentiation cell type cellular oncology disease /disorder model furans gap junctions gastrointestinal epithelium gene expression growth factor receptors hepatocyte growth factor laboratory rat liver cells membrane channels metaplasia model design /development neoplasm /cancer classification /staging neoplastic transformation protooncogene simian virus 40 tissue /cell culture transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from the investigator's abstract): Evidence was
previously obtained from novel in vivo rat models of severe liver injury
and intrahepatic cholangiocarcinogenesis induced by furan to strongly
suggest that typical hyperplastic bile ductular epithelial cells can
alter their commitment to differentiate along the biliary cell lineage
so as to act as facultative cell progenitors of either metaplastic small
intestinal-like glands or of unique ductular hepatocytic-like cells.
Moreover, a very high incidence of biliary cell-derived "intestinal-
type" adenocarcinomas preferentially developed in the livers of the furan
treated rats. To more definitively establish if typical hyperplastic
bile ductular epithelial cells are capable of acting as a facultative
pluripotent stem-like cell during cholangiocarcinogenesis and in certain
types of severe hepatic injury, the following specific aims will be
pursued: (1) Achieve neoplastic transformation of cultured populations
of rat hyperplastic bile ductular epithelial cells that are clearly
distinct from proliferating rat liver oval cell populations for the
purpose of establishing for the first time the differentiation potential
of these more typical bile ductular cells when converted to their
tumorigenic phenotype by selected in vitro transforming treatments; (2)
Based on the preliminary findings, determine if (a) cotransfection of
both the c-met protooncogene, which encodes the receptor for hepatocyte
growth factor/scatter factor (HGF/SF), and the HGF/SF growth factor gene
into cultured populations of rat hyperplastic bile ductular epithelial
cells in tumorigenic, and (b) if the overexpression of these respective
genes may correlate with a preferential differentiation of transformed
biliary cells along the small intestinal lineage; and (3) Use gap
junction genes as molecular biomarkers to further establish the temporal
lineage relationship between hyperplastic bile ductular epithelial cell
types and ductular hepatocytes that form in the rat liver in response
to severe hepatic injury induced by furan. It is anticipated that the
results generated by the proposed research are likely to contribute in
a significant way to furthering our current understanding of the hepatic
stem cell hypothesis, as well as to add considerably to our present
knowledge of the cellular origins and histogenesis of hepatobiliary
cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
-
批准号:10747566
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2023
-
负责人:ALPHONSE E SIRICA
-
依托单位:
FASEB Growth Factor Receptor Tyrosine Kinases Confence
-
批准号:6359929
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2001
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7172654
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
-
批准号:6023971
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6693829
-
项目类别:
-
资助金额:$26.19万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6865103
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7339683
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
-
批准号:6350400
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:8499770
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7558284
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:8829763
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:9228939
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6628421
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6497936
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7009272
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
FASEB GROWTH FACTOR RECEPTOR TYROSINE KINASES CONFERENCE
-
批准号:2869480
-
项目类别:
-
资助金额:$0.9万
-
财政年份:1999
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:2089765
-
项目类别:
-
资助金额:$22.15万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:6137427
-
项目类别:
-
资助金额:$26.92万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:7812168
-
项目类别:
-
资助金额:$28.9万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:7305108
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
-
批准号:30840003
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:2008
-
负责人:焦宇飞
-
依托单位: